Monday, July 14, 2014

Fourth Question of the Day July 14, 2014 Why did PCCA invest in Imprimis Pharmaceuticals, Inc.? Why was PCCA's investiment so important for its members? Here are a few documents and a youtube video that mgiht shed light on it.



September 8, 2012

Dear PCCA Member, This past Friday, September 7, 2012, Imprimis Pharmaceuticals, Inc. announced that it had signed an agreement with PCCA to assist them with drug development. It also was announced that PCCA made a $4 million investment in Imprimis. Imprimis already finalized phase 2 clinical trials, and is now beginning phase 3 trials in their quest for FDA-approval for Impracor™, a ketoprofen in PLO product. In our discussions with the company regarding the patent for PLO, which Imprimis purchased from a PCCA member, we saw an opportunity to protect PCCA members by working with Imprimis and putting specific safeguards in place to protect PCCA members compounding PLO and ketoprofen. We believe that we now have the opportunity to grow compounding for our members, especially with the use of transdermals. When manufactured drugs are not a good fit for patients, prescribers turn to compounders to deliver customized options. As these Imprimis PLO-based products find new patients, our industry will find additional patients that these "one size fits all" drugs cannot help. Below is a summary of our agreement with Imprimis, information about our upcoming webinar, and a list of answers to questions you may have. Thank you for your commitment to your patients and to PCCA.


Jim Smith PCCA President
quoted from here

  1. [PDF]

  2. Imprimis Pharmaceuticals, Inc. and PCCA - PCCA Customer ...

  1. wow.pccarx.com/Documents/M-Files/98496_ImprimisAnnouncemt.pdf
  1. Sep 8, 2012 - that PCCA made a $4 million investment in Imprimis. Imprimis already finalized phase 2 clinical trials, and is now beginning phase 3 trials in ...

    1. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property ...

    1. www.prnewswire.com/.../imprimis-pharmaceuticals-inc-acquires-intellect...
    Jun 17, 2013 - The acquisition allows Imprimis to pursue the commercial ... This IP acquisition is the first to emerge from the Imprimis-PCCA relationship.

    1. Strategic Agreement Launches Novel Drug Development ...

    1. imprimispharma.com/.../strategic-agreement-launches-novel-drug-develo...
    Sep 7, 2012 - Professional Compounding Centers of America (PCCA) Invests $4 Million In San Diego-based Imprimis Pharmaceuticals; Agrees to Share ...

    1. Imprimis Pharmaceuticals Begins Enacting Long-Term ...

    1. www.biomedreports.com/.../imprimis-pharmaceuticals-be...
    1. BioMedReports
    3. Loading...
    5. Jun 26, 2013 - In 2012 Imprimis entered a relationship with Professional Compounding Centers of America, Inc. (PCCA). This relationship provides Imprimis ...

      1. Imprimis Pharmaceuticals Is Primed to Change an $11 ...

      1. beta.fool.com/ilanagreene/2013/06/13/imprimis...is-primed.../37140/
      Jun 13, 2013 - The connection between Imprimis and PCCA is of vital interest to investors. PCCA is North America's largest compounding pharmaceutical ...

    1. PCCA & Imprimis Partnership Announcment - Jim Smith ...

    2. Video for imprimis pcca► 5:07
    1. www.youtube.com/watch?v=Knk0jWmWZtc
    1. Sep 14, 2012 - Uploaded by pccarx
    2. Jim Smith, President of PCCA, talks about the new partnership between PCCA & Imprimis. Details about ...

    1. Exhibit 99.1 Executive Summary

    1. www.sec.gov/.../f8k052113_e...
    1. U.S. Securities and Exchange Commission
    3. Loading...
    5. Imprimis is in the process of analyzing the PCCA development assets and expects to begin additional internal development projects over the next three years, ...

      1. Imprimis, PCCA in Drug Delivery Alliance - Contract Pharma

      1. www.contractpharma.com/.../imprimis-pcca-in-drug-delivery-alliance/
      Sep 7, 2012 - The agreement gives Imprimis access to PCCA's topical technologies and formulation expertise for transdermal drug delivery.

    1. Imprimis Pharmaceuticals acquires Buderer intellectual ...

    1. www.centerwatch.com/.../imprimis-pharmaceuticals-acquire...
    1. CenterWatch
    3. Loading...
    5. Jun 18, 2013 - Imprimis Pharmaceuticals has acquired the intellectual property (IP) rights ... Buderer Drug, a compounding pharmacy member of PCCA.
    • -

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)